Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Phase III study of Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone (Isa-KRd) versus Carfilzomib-Lenalidomide-Dexamethasone (KRd) in newly diagnosed multiple myeloma patients eligible for autologous stem cell transplantation (IsKia TRIAL)
Sponsor European Myeloma Network B.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A MULTICENTER, RANDOMIZED, OPEN LABEL PHASE II STUDY OF CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CCyd) as pre transplant INDUCTION and post transplant consolidation or CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (CRd) as pre transplant INDUCTION and post transplant consolidation or continuous treatment with CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (12 cycles) without transplant, all followed by MAINTENANCE with LENALIDOMIDE (R) versus LENALIDOMIDE AND CARFILZOMIB (CR) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS ELEGIBLE FOR AUTOLOGOUS TRANSPLANT
Sponsor Universita' Degli Studi Di Torino
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino?
The 2026-10-09 snapshot links Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino to 2 distinct CTIS trials. Recorded services include Laboratory services, Routine clinical pathology testing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino conducted?
The linked trials record locations in 8 countries, including Italy, Belgium, Czechia, Germany, Spain. These are trial locations, not confirmed office locations or countries where Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino delivered services.
What can this page tell me about Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino